Recent advances in the discovery and delivery of vaccine adjuvants
Top Cited Papers
- 1 September 2003
- journal article
- review article
- Published by Springer Nature in Nature Reviews Drug Discovery
- Vol. 2 (9) , 727-735
- https://doi.org/10.1038/nrd1176
Abstract
Adjuvant design has historically had a touch of alchemy at its heart due to its reliance on the complex biology of innate immune activation. However, a new mechanistic understanding of innate immunity, combined with new adjuvant and delivery platforms for exploiting this knowledge, has led to significant advances recently. Although many challenges remain, the field is moving rapidly and the proper tools and methodologies are in place for the use of traditional drug discovery engines in guiding the development of vaccine adjuvants. In this review, we outline the current trends in immune potentiator, delivery system and adjuvant design that will shape the vaccines of the future.Keywords
This publication has 62 references indexed in Scilit:
- Maintenance of Serological Memory by Polyclonal Activation of Human Memory B CellsScience, 2002
- Combinations of Protein Polysaccharide Conjugate Vaccines for Intranasal ImmunizationThe Journal of Infectious Diseases, 2002
- A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responsesVaccine, 2002
- Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848Nature Immunology, 2002
- Immunization with the adjuvant MF59 induces macrophage trafficking and apoptosisEuropean Journal of Immunology, 2001
- Oral Administration of Influenza Vaccine in Combination with the Adjuvants LT-K63 and LT-R72 Induces Potent Immune Responses Comparable to or Stronger than Traditional Intramuscular ImmunizationClinical and Diagnostic Laboratory Immunology, 2001
- Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cellsGene Therapy, 2000
- Adjuvant Activities of Immune Response Modifier R-848: Comparison with CpG ODNCellular Immunology, 2000
- Clinical immunogenicity and tolerance studies of liquid vaccines delivered by jet-injector and a new single-use cartridge (Imule®): comparison with standard syringe injectionVaccine, 1997
- Safety and Immunogenicity of Env 2-3, a Human Immunodeficiency Virus Type 1 Candidate Vaccine, in Combination with a Novel Adjuvant, MTP-PE/MF59AIDS Research and Human Retroviruses, 1996